Hemington Wealth Management Purchases 63 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Hemington Wealth Management grew its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 5.9% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,126 shares of the healthcare conglomerate’s stock after buying an additional 63 shares during the quarter. Hemington Wealth Management’s holdings in UnitedHealth Group were worth $569,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds and other institutional investors have also recently modified their holdings of UNH. International Assets Investment Management LLC raised its holdings in UnitedHealth Group by 78,814.4% in the 3rd quarter. International Assets Investment Management LLC now owns 5,296,737 shares of the healthcare conglomerate’s stock worth $3,096,896,000 after purchasing an additional 5,290,025 shares during the period. Accredited Investors Inc. raised its holdings in UnitedHealth Group by 9,235.4% in the 3rd quarter. Accredited Investors Inc. now owns 784,924 shares of the healthcare conglomerate’s stock worth $458,929,000 after purchasing an additional 776,516 shares during the period. Raymond James & Associates raised its holdings in UnitedHealth Group by 33.1% in the 3rd quarter. Raymond James & Associates now owns 2,361,396 shares of the healthcare conglomerate’s stock worth $1,380,661,000 after purchasing an additional 587,088 shares during the period. Caisse DE Depot ET Placement DU Quebec raised its holdings in UnitedHealth Group by 129.7% in the 3rd quarter. Caisse DE Depot ET Placement DU Quebec now owns 1,029,540 shares of the healthcare conglomerate’s stock worth $601,951,000 after purchasing an additional 581,324 shares during the period. Finally, State Street Corp raised its holdings in UnitedHealth Group by 1.3% in the 3rd quarter. State Street Corp now owns 45,540,102 shares of the healthcare conglomerate’s stock worth $26,626,387,000 after purchasing an additional 563,554 shares during the period. 87.86% of the stock is owned by institutional investors.

UnitedHealth Group Stock Down 1.2 %

Shares of NYSE UNH opened at $527.31 on Thursday. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. The company has a market cap of $485.27 billion, a P/E ratio of 34.02, a PEG ratio of 1.45 and a beta of 0.61. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $630.73. The firm has a 50-day simple moving average of $526.25 and a two-hundred day simple moving average of $563.96.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.74 by $0.07. The business had revenue of $100.81 billion during the quarter, compared to the consensus estimate of $101.60 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The firm’s quarterly revenue was up 6.8% compared to the same quarter last year. During the same quarter last year, the firm earned $5.83 earnings per share. Research analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

Insider Activity

In related news, Director Timothy Patrick Flynn purchased 1,000 shares of the firm’s stock in a transaction dated Friday, January 17th. The stock was purchased at an average price of $511.57 per share, with a total value of $511,570.00. Following the completion of the purchase, the director now owns 4,500 shares of the company’s stock, valued at approximately $2,302,065. The trade was a 28.57 % increase in their position. The acquisition was disclosed in a filing with the SEC, which is available at the SEC website. Insiders own 0.33% of the company’s stock.

Analyst Ratings Changes

A number of equities research analysts have commented on the company. UBS Group decreased their price target on UnitedHealth Group from $680.00 to $650.00 and set a “buy” rating on the stock in a report on Wednesday, October 16th. HSBC raised UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 price target on the stock in a report on Friday, January 10th. KeyCorp reissued an “overweight” rating and set a $650.00 price target on shares of UnitedHealth Group in a report on Friday, January 17th. Cantor Fitzgerald restated an “overweight” rating and set a $700.00 price objective on shares of UnitedHealth Group in a research report on Friday, January 17th. Finally, Truist Financial cut their price objective on UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating for the company in a research report on Monday, January 6th. One investment analyst has rated the stock with a hold rating, twenty have issued a buy rating and two have assigned a strong buy rating to the company. According to data from MarketBeat, the company has an average rating of “Buy” and a consensus price target of $629.32.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.